Term
|
Definition
Beta Antagonist
(beta blocker)
Nonselective sympathetic beta antagonist - decrease BP |
|
|
Term
|
Definition
Beta-1 antagonist
Cardioselective (decrease BP) |
|
|
Term
|
Definition
Alpha-2 agonist
Sympatholytic and indirect (stop NE release) |
|
|
Term
|
Definition
Alpha-1 antagonist
(causes vasodilation) |
|
|
Term
|
Definition
all alpha-1 antagonist
-these vasodilate (for tx of hypertension and BPH) |
|
|
Term
|
Definition
Beta-1 and beta-2 agonist |
|
|
Term
|
Definition
Beta-1 selective agonist (increase HR) |
|
|
Term
|
Definition
Beta blockers
(sympathetic antagonist for Beta-1 and Beta-2) |
|
|
Term
|
Definition
Inhibits reuptake of sympathetic NE. This is an indirect agonist. |
|
|
Term
|
Definition
Causes vesicular release. This is an indirect sympathetic agonist. |
|
|
Term
|
Definition
Causes vesicle release (indirect) and is a nonselective direct agonist. |
|
|
Term
|
Definition
Causes release of vesicle to be inhibited. This is indirect. |
|
|
Term
Tyrosine Hydroxylase Inhibitor |
|
Definition
Inhibits synthesis of NE. Indirect. |
|
|
Term
|
Definition
A thiazide. It works on the distal tubule.
-Blocks NaCl co-transporter, so salt stays in urine, and hence you pee more.
Side effects: hypokalemia and hypouricemia |
|
|
Term
|
Definition
Loop diuretic
-act on thick, ascending limb to prevent NaCl reabsorption, specifically from a Na/K/2Cl transporter.
Side effects: hypokalemia and hyperuricemia |
|
|
Term
|
Definition
Potassium sparing diuretic.
-antagonist at the mineralocorticoid receptor. they block aldosterone from having an effect. normally aldosterone would increase Na/K ATPase, which promotes sodium reabsorption. Instead, we're blocking aldosterone from binding to MR receptor. so it's an MR antagonist. |
|
|
Term
|
Definition
Potassium sparing diuretic
Blocks Na channels on the lumen. |
|
|
Term
|
Definition
alpha-2 agonist
-Works on solitary nucleus. It reduces sympathetic nervous system activity |
|
|
Term
|
Definition
Inhibits the vesicular release of NE |
|
|
Term
|
Definition
Nonselective beta blocker. decreases BP.
-Direct acting |
|
|
Term
|
Definition
Selective for Beta-1 antagonist.
-Cardioselective beta-blocker |
|
|
Term
|
Definition
Alpha-1 antagonist
-vasodilate |
|
|
Term
|
Definition
Alpha-1 antagonist
-vasodilate |
|
|
Term
|
Definition
-oral drug. selective arterial dilator.
-keeps potassium channels open |
|
|
Term
|
Definition
highly effective vasodilator.
-used for severe hypertension
-lots of side effects: hypertrichosis
-keeps potassium channels open |
|
|
Term
Sodium nitroprusside (a nitrate) |
|
Definition
-used in emergency situations. and is too efficacious with too many side effects for outpatient use.
-it's a IV nitrate drug.
-it's dinitrated to nitric oxide (a vasodilator) and acts to hyperpolarize the neuron by keeping K channels open. |
|
|
Term
|
Definition
Block voltage-gated dependent calcium channes, thereby preventing actin/myosin binding, so you can't get smooth muscle contraction |
|
|
Term
|
Definition
Cardioactive. Will relax smooth muscle AND reduce cardiac output (decrease HR, AV conduction, and force of contraction) |
|
|
Term
|
Definition
Non-cardioactive and relax smooth muscles but have little effect on cardiac output
-all end in -dipine |
|
|
Term
|
Definition
longer-acting dihydropyridines (CCBs) at 30-50 hours |
|
|
Term
|
Definition
Shorter acting Dihydropyridines (CCBs) at 4 hours.
-increased risk of MI |
|
|
Term
|
Definition
These are inhibiting the conversion of angiotesin I to angiotensin II at ACE.
-end in -pril
-Side effects: due to bradykinin (less metabolism with ACE inhibitors) such as dry cough, angioedema; also hyperkalemia, and reduced kidney function (good for diabetic) |
|
|
Term
|
Definition
ACE inhibitor with no metabolism necessary |
|
|
Term
|
Definition
Pro-drug metabolized to active ACE inhibitor |
|
|
Term
Angiotensin receptor blockers (ARBs) |
|
Definition
These inhibit binding of angiotensin II to the AT1 receptor, but spare side effects of bradykinin increase (that you got with ACE inhibitors) |
|
|
Term
|
Definition
angiotensin receptor blocker |
|
|
Term
|
Definition
Angiotensin receptor blockers |
|
|
Term
|
Definition
Inhibits the conversion of angiotensinogen to angiotensin I by blocking the enzyme renin.
So they're a renin-inhibitor |
|
|
Term
|
Definition
indirectly inhibit thrombin via anti-thrombin III |
|
|
Term
|
Definition
Low molecular weight heparin
-less efficacy |
|
|
Term
|
Definition
-better efficacy, but greater bleed risk |
|
|
Term
Direct Thrombin Inhibitors (DTI's) |
|
Definition
analogs of Hirudin (purified from medicinal leeches) they directly inhibit thrombin. |
|
|
Term
|
Definition
|
|
Term
|
Definition
Only oral anticoagulant
-It prevents the synthesis of clotting factors by inactivating Vitamin K epoxide reductase .
-slower than heparin. |
|
|
Term
Tissue plasminogen activator |
|
Definition
promotes the conversion of plasminogen to plasmin |
|
|
Term
|
Definition
|
|
Term
|
Definition
-aspirin, ADP receptor blockers, GP IIa/IIIb blockers |
|
|
Term
|
Definition
TPA purified from bacteria |
|
|
Term
|
Definition
|
|
Term
|
Definition
Inhibits COX-1 from making TXA2 (which would cause platelet aggregation) |
|
|
Term
|
Definition
prevents ADP from binding to platelet purinergic receptors |
|
|
Term
|
Definition
a pro-drug activated by CYP's for ADP receptor blockers |
|
|
Term
|
Definition
used for PCI patients - antiplatelet |
|
|
Term
|
Definition
GP IIa/IIIb blockers. These are anti-GPIIb/IIIa antibody. It binds directly to GP IIb/IIIa |
|
|
Term
|
Definition
Gb IIa/IIIb antagonist. binds directly to GP IIb/IIIa receptor |
|
|
Term
|
Definition
increase HDL, decrease VLDL (by decreasing synthesis and increasing lipoprotein lipase) and decrease LDL (by decreasing VLDL) |
|
|
Term
Fibric acid derivatives/fibrates |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
prevents bile acid reabsorption, so it gets eliminated!
-therefore you need to increase LDL receptors to get more LDL in the liver cells to make more cholesterol for bile! |
|
|
Term
|
Definition
|
|
Term
|
Definition
inhibit HMG-CoA reductase
-ergo preventing cholesterol synthesis |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
binds to protein on GI epithelial cells that promotes cholesterol absorption in the small intestine. So you're inhibiting absorption of dietary cholesterol |
|
|
Term
|
Definition
Simvastatin/Ezetimibe
-combo drug
-it produced greater reductions in LDL than simvastatin alone, but no different in coronary atherosclerotic plaque. |
|
|
Term
|
Definition
These dilate veins (reduce preload and oxygen demand) and dilate arteries (increase oxygen supply via coronary arteries) more than resistance arteries.
Note: high tolerance and toxic effects of headache, flushing/sweating and hypotension |
|
|
Term
|
Definition
Nitroglycerin is very effectively metabolized when given orally due to first pass effects. you can avoid this by giving nitroglycerine sublingually. This is because blood supply in mouth is different than hepatoportal system that shunts right to the liver.
Note: there are also sprays &transdermal patches |
|
|
Term
|
Definition
organic nitrate that can be administered orally |
|
|
Term
|
Definition
These are organic nitrates that can be administered orally. |
|
|
Term
Calcium Channel Blockers (CCBs) |
|
Definition
These are especially useful for Variant Angina Pectoris. They can be used for classic, but only when others aren't an option. |
|
|
Term
When do you use cardioactive CCBs and when do you use noncardioactive CCBs? |
|
Definition
-Use cardioactive CCBs when by themselves
-Use non-cardioactive when used with beta blockers.
Note: they should not be used when unstable or with people who have a history of acute MI. |
|
|
Term
|
Definition
Non-cardioactive CCB. They block channels in vascular smooth muscle without large effects on cardiac muscles. They're vasodilators only!! |
|
|
Term
|
Definition
Non-cardioactive CCB. They block channels in vascular smooth muscle without large effects on cardiac muscles. They're vasodilators only!!
AKA amlodipine!
|
|
|
Term
|
Definition
Cardioactive CCB. They block channels in vascular smooth muscle AND in the heart. So they are a vasodilator AND cardiac inhibitor. |
|
|
Term
|
Definition
Best for classic angina. They decrease oxygen demand by decreasing heart rate and decreased contractile force.
Note: may precipitate vasospasm in people with variant angina |
|
|
Term
|
Definition
Non-selective beta blocker |
|
|
Term
|
Definition
Cardioselective beta blocker |
|
|
Term
|
Definition
An anti-platelet drug that protects against acute MI or during a heart attack prevents against re-occlusion against heart attack. |
|
|
Term
|
Definition
An antiplatelet drug that is an ADP blocker. This is for higher-risk individuals. They can be used post-MI or post-PCI surgery. They block platelet aggregation. |
|
|
Term
|
Definition
These are anti-platelet drugs that are glycoprotein IIa/IIIb blockers. Use them during PCI surgery. They prevent fibrinogen binding. |
|
|
Term
|
Definition
These are anti-platelet drugs that are glycoprotein IIa/IIIb blockers. Use them during PCI surgery. They prevent fibrinogen binding.
|
|
|
Term
|
Definition
Tissue plasminogen activation. Breaks down fibrin components of clots to open vessels after coronary occlusion has already occurred. They are effective at clearing clots 50% of the time. They're usually given IV or intra-arterially. |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
Increases cardiac output by increasing myocardial contractility as a result of effects on calcium. Used for congestive heart failure. |
|
|
Term
Digitalis/Cardiac Glycosides |
|
Definition
Used to be first-line treatment, but now only used in specific populations. You can't switch from digitalis glycosides to ACE inhibitors without deterioration of condition |
|
|
Term
|
Definition
How you treat overdose (since there's a very low margin of safety and you have a high risk of cardiac arrthmias) |
|
|
Term
|
Definition
An ACE inhibitor that blocks the conversion of angiotensin I to angiotensin II. The therapeutic effects are at AT1 receptors to relax arterial smooth muscle (and reduce afterload) and to reduce aldosterone production/release (and reduce sodium reabsorption and blood volume=reduce preload). also by unknown mechanisms they dilate veins (reduce venous return and preload) and reduce trophic changes in the myocardium (and prevent/reverse myocardial hypertrophy-remodeling) |
|
|
Term
|
Definition
ACE inhibitor. Used for congestive heart failure. |
|
|
Term
|
Definition
For unknown reasons, ACE inhibitors are more effective than angiotensin blockers. ARBs should only be used in patients who can't tolerate ACE inhibitors. |
|
|
Term
|
Definition
Antagonist at aldosterone (mineralocorticoid receptors). They prevent effects of aldosterone on sodium/potassium exchange in the kidneys. Also prevents other non-renal effects of aldosterone, possibly in the heart (remodeling) and the lungs (reduced edema/congestion). Used for congestive heart failure. |
|
|
Term
|
Definition
A thiazide diuretic. It has moderate efficacy but produces hypokalemia. Used for congestive heart failure. |
|
|
Term
|
Definition
A diuretic at the loop of henle. it has high efficacy but produces hypokalemia. Used for congestive heart failure. |
|
|
Term
|
Definition
An arterial dilator that decreases afterload. Good for treating patients with fatigue as a primary symptom. Used for congestive heart failure. |
|
|
Term
|
Definition
Venous dilator/nitrate that decreases preload. Good for treating patients with pulmonary edema as a primary symptom. Used for congestive heart failure. |
|
|
Term
|
Definition
Beta blocker with alpha-1 antagonist effect. Therefore it will vasodilate and actually reduce CO, but appear to improve survival in some patients. Used for congestive heart failure. |
|
|
Term
|
Definition
Cardioselective beta blocker. selective at beta-1 receptors. Somehow it reduces heart rate which may restore synchonized filling and contraction of the heart. Possibly reduced remodeling (cardiac hypertrophy) too. Used for congestive heart failure. |
|
|
Term
|
Definition
Cardioselective beta blocker. selective at beta-1 receptors. Somehow it reduces heart rate which may restore synchonized filling and contraction of the heart. Possibly reduced remodeling (cardiac hypertrophy) too. Used for congestive heart failure.
|
|
|
Term
|
Definition
A phosphodiesterase 3 (PDE3) inhibitor. Blocking PDE means you get an accumulation of cAMP with results in positive ionotropic effects. This accumulation allows you to increase the activity of heart cells. Used for acute heart failure. |
|
|
Term
|
Definition
Beta-1 adrenergic receptor agonists. It's a selective beta-1 agonist. Used for acute heart failure. |
|
|
Term
|
Definition
An muscarinic antagonist that blocks effects of the ParaNS on heart. This allows you to have a greater activation of SympNS since you're removing parasympathetic inhibition. Used for acute heart failure. |
|
|
Term
|
Definition
These dilate veins (reduce preload and oxygen demand) and dilate arteries (increase oxygen supply via coronary arteries) more than resistance arteries.
Note: high tolerance and toxic effects of headache, flushing/sweating and hypotension |
|
|
Term
|
Definition
Nitroglycerin is very effectively metabolized when given orally due to first pass effects. you can avoid this by giving nitroglycerine sublingually. This is because blood supply in mouth is different than hepatoportal system that shunts right to the liver.
Note: there are also sprays &transdermal patches |
|
|
Term
|
Definition
organic nitrate that can be administered orally |
|
|
Term
|
Definition
These are organic nitrates that can be administered orally. |
|
|
Term
Calcium Channel Blockers (CCBs) |
|
Definition
These are especially useful for Variant Angina Pectoris. They can be used for classic, but only when others aren't an option. |
|
|
Term
When do you use cardioactive CCBs and when do you use noncardioactive CCBs? |
|
Definition
-Use cardioactive CCBs when by themselves
-Use non-cardioactive when used with beta blockers.
Note: they should not be used when unstable or with people who have a history of acute MI. |
|
|
Term
|
Definition
Non-cardioactive CCB. They block channels in vascular smooth muscle without large effects on cardiac muscles. They're vasodilators only!! |
|
|
Term
|
Definition
Non-cardioactive CCB. They block channels in vascular smooth muscle without large effects on cardiac muscles. They're vasodilators only!!
AKA amlodipine!
|
|
|
Term
|
Definition
Cardioactive CCB. They block channels in vascular smooth muscle AND in the heart. So they are a vasodilator AND cardiac inhibitor. |
|
|
Term
|
Definition
Best for classic angina. They decrease oxygen demand by decreasing heart rate and decreased contractile force.
Note: may precipitate vasospasm in people with variant angina |
|
|
Term
|
Definition
An anti-platelet drug that protects against acute MI or during a heart attack prevents against re-occlusion against heart attack. |
|
|
Term
|
Definition
An antiplatelet drug that is an ADP blocker. This is for higher-risk individuals. They can be used post-MI or post-PCI surgery. They block platelet aggregation. |
|
|
Term
|
Definition
These are anti-platelet drugs that are glycoprotein IIa/IIIb blockers. Use them during PCI surgery. They prevent fibrinogen binding. |
|
|
Term
|
Definition
These are anti-platelet drugs that are glycoprotein IIa/IIIb blockers. Use them during PCI surgery. They prevent fibrinogen binding.
|
|
|
Term
|
Definition
Tissue plasminogen activation. Breaks down fibrin components of clots to open vessels after coronary occlusion has already occurred. They are effective at clearing clots 50% of the time. They're usually given IV or intra-arterially. |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
Increases cardiac output by increasing myocardial contractility as a result of effects on calcium. Used for congestive heart failure. |
|
|
Term
Digitalis/Cardiac Glycosides |
|
Definition
Used to be first-line treatment, but now only used in specific populations. You can't switch from digitalis glycosides to ACE inhibitors without deterioration of condition |
|
|
Term
|
Definition
How you treat overdose (since there's a very low margin of safety and you have a high risk of cardiac arrthmias) |
|
|
Term
|
Definition
An ACE inhibitor that blocks the conversion of angiotensin I to angiotensin II. The therapeutic effects are at AT1 receptors to relax arterial smooth muscle (and reduce afterload) and to reduce aldosterone production/release (and reduce sodium reabsorption and blood volume=reduce preload). also by unknown mechanisms they dilate veins (reduce venous return and preload) and reduce trophic changes in the myocardium (and prevent/reverse myocardial hypertrophy-remodeling) |
|
|
Term
|
Definition
For unknown reasons, ACE inhibitors are more effective than angiotensin blockers. ARBs should only be used in patients who can't tolerate ACE inhibitors. |
|
|
Term
|
Definition
Antagonist at aldosterone (mineralocorticoid receptors). They prevent effects of aldosterone on sodium/potassium exchange in the kidneys. Also prevents other non-renal effects of aldosterone, possibly in the heart (remodeling) and the lungs (reduced edema/congestion). Used for congestive heart failure. |
|
|
Term
|
Definition
A thiazide diuretic. It has moderate efficacy but produces hypokalemia. Used for congestive heart failure. |
|
|
Term
|
Definition
A diuretic at the loop of henle. it has high efficacy but produces hypokalemia. Used for congestive heart failure. |
|
|
Term
|
Definition
An arterial dilator that decreases afterload. Good for treating patients with fatigue as a primary symptom. Used for congestive heart failure. |
|
|
Term
|
Definition
Venous dilator/nitrate that decreases preload. Good for treating patients with pulmonary edema as a primary symptom. Used for congestive heart failure. |
|
|
Term
|
Definition
Beta blocker with alpha-1 antagonist effect. Therefore it will vasodilate and actually reduce CO, but appear to improve survival in some patients. Used for congestive heart failure. |
|
|
Term
|
Definition
Cardioselective beta blocker. selective at beta-1 receptors. Somehow it reduces heart rate which may restore synchonized filling and contraction of the heart. Possibly reduced remodeling (cardiac hypertrophy) too. Used for congestive heart failure. |
|
|
Term
|
Definition
Cardioselective beta blocker. selective at beta-1 receptors. Somehow it reduces heart rate which may restore synchonized filling and contraction of the heart. Possibly reduced remodeling (cardiac hypertrophy) too. Used for congestive heart failure.
|
|
|
Term
|
Definition
A phosphodiesterase 3 (PDE3) inhibitor. Blocking PDE means you get an accumulation of cAMP with results in positive ionotropic effects. This accumulation allows you to increase the activity of heart cells. Used for acute heart failure. |
|
|
Term
|
Definition
Beta-1 adrenergic receptor agonists. It's a selective beta-1 agonist. Used for acute heart failure. |
|
|
Term
|
Definition
An muscarinic antagonist that blocks effects of the ParaNS on heart. This allows you to have a greater activation of SympNS since you're removing parasympathetic inhibition. Used for acute heart failure. |
|
|
Term
|
Definition
Thiazide! -inhibits sodium reabsorption from distal tubule! -usually for long-term HTN management |
|
|
Term
|
Definition
High efficacy loop diuretic -short-term HTN management |
|
|
Term
|
Definition
Potassium Sparing Diuretic |
|
|
Term
|
Definition
|
|
Term
|
Definition
Vasodilator Highly effective and long-acting Parenteral - not a first choice drug. |
|
|
Term
|
Definition
|
|
Term
|
Definition
Beta blocker that promotes nitric oxide (NO) production. |
|
|
Term
|
Definition
|
|
Term
|
Definition
ADP receptor Blocker. -aka Effient -A prodrug but metabolized by different CYP enzymes than Clopidogrel. -More consistent effects |
|
|
Term
|
Definition
Procoagulants -Prevent plasmin formation - promote clotting |
|
|
Term
|
Definition
Facilitate the natural hemostatic process. -ie: vasoconstrictors, clotting factors, collagen/cellulose sheets |
|
|
Term
|
Definition
Reverses effects of Warfarin |
|
|
Term
|
Definition
Reverses effects of Heparin |
|
|
Term
|
Definition
Bile Acid Sequestrants -reduce LDL and increase HDL -best tolerated |
|
|
Term
|
Definition
Bile Acid Sequestrants -reduce LDL, increase HDL |
|
|
Term
|
Definition
|
|
Term
What do Class I Antiarrythmics do? |
|
Definition
Block fast voltage-dependent sodium channels |
|
|
Term
What do Class II Antiarrythmics do? |
|
Definition
|
|
Term
What do Class III Antiarrythmics do? |
|
Definition
|
|
Term
What do Class IV Antiarrhythmics do? |
|
Definition
|
|
Term
|
Definition
Quinidine and Procainamide |
|
|
Term
|
Definition
lidocaine and mexilentine |
|
|
Term
|
Definition
|
|
Term
Which beta blockers are used as anti-arrhythmics? |
|
Definition
|
|
Term
Which drugs are used as Class III antiarrhythmics? |
|
Definition
Ibulitide, sotalol, amiodarone |
|
|
Term
Which drugs are class IV antiarrhythmics? |
|
Definition
|
|